(Press-News.org) HIV and its transmission has long been associated with injecting drug use, where hypodermic syringes are used to administer illicit drugs. Now, a newly reported study by researchers affiliated with New York University's Center for Drug Use and HIV Research (CDUHR) in the journal PLOS ONE, shows that HIV infection among heterosexual non-injecting drug users (no hypodermic syringe is used; drugs are taken orally or nasally) in New York City (NYC) has now surpassed HIV infection among persons who inject drugs.
The study, "HSV-2 Co-Infection as a Driver of HIV Transmission among Heterosexual Non-Injecting Drug Users in New York City," was conducted among drug users entering the Mount Sinai Beth Israel drug treatment programs in NYC. The researchers found that HIV infection among non-injecting drug users doubled over the last two decades, from 7% infected in the late 1990s (n= 785) to 14% (n=1764) currently. During this same time-frame, HIV infection among persons who inject drugs fell to 10%.
The increased efficiency for transmitting HIV occurs even when persons with herpes simplex virus 2 (HSV-2) are between outbreaks, as herpes increases both susceptibility to and transmissibility of HIV. More than half of the non-injecting drug users in the study were infected with HSV-2.
"Heterosexual intercourse is usually not very efficient for transmitting HIV, but the efficiency of heterosexual transmission nearly triples in the presence of herpes simplex virus type 2," notes the study's lead author, Don Des Jarlais, PhD, Deputy Director, Research Methods and Infectious Diseases Cores, Center for Drug Use and HIV Research (CDUHR) and Professor of Psychiatry and of Preventive Medicine at Mount Sinai Beth Israel. "In New York City, we have done an excellent job of reducing HIV among persons who inject drugs and we must now put more efforts into reducing sexual transmission associated with non-injecting drug use."
The study concludes that an increase in HIV infection among these non-injecting drug users is better considered as an increase in HSV- 2/HIV co-infection rather than simply an increase in HIV prevalence. Additional interventions (such as treatment as prevention and pre-exposure prophylaxis) are needed to reduce further HIV transmission from HSV-2/HIV co-infected non-injecting drug users.
The City Department of Health and Mental Hygiene has initiated a program "treatment as prevention," in which HIV infected persons are given anti-viral medications to both protect their own health and to reduce the chances that they will transmit HIV to others. There are also new federal recommendations to provide anti-retroviral medications to HIV uninfected persons at high risk for becoming infected.
"If we can implement these programs on a large scale, we should be able to control sexual transmission of HIV in the city, and achieve the goal of an "End to the AIDS Epidemic," said Dr. Des Jarlais.
INFORMATION:
Authors and affiliations: Don C. Des Jarlais, Kamyar Arasteh, Courtney McKnight, David C. Perlman, and Jonathan Feelemyer: The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York, United States of America; Holly Hagan, College of Nursing, New York University, New York, New York, United States of America; Hannah L. F. Cooper, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Funding: This work received support from the National Institutes of Health (NIH)under NIH Grant# 5 R01 DA 03574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
About CDUHR
The mission of CDUHR is to end the HIV and HCV epidemics in drug using populations and their communities by conducting transdisciplinary research and disseminating its findings to inform programmatic, policy, and grass roots initiatives at the local, state, national, and global levels. The Center is dedicated to increasing the understanding of the substance use-HIV/AIDS epidemic, particularly among individuals in high-risk contexts. The Center's theme is "Discovery to Implementation & Back: Research Translation for the HIV/Substance Use Epidemic."
About the Mount Sinai Health System
Rebecca Spitz, MSBI | 212-523-4044 | rspitz@chpnet.org
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report. For more information, visit http://www.mountsinai.org/
About New York University College of Nursing
NYU College of Nursing is a global leader in nursing education, research, and practice. It offers a Bachelor of Science in Nursing, a Master of Science and Post-Master's Certificate Programs, a Doctor of Philosophy in Research Theory and Development, and a Doctor of Nursing Practice degree. For more information, visit nursing.nyu.edu
Herpes virus infection drives HIV infection among non-injecting drug users in New York
2014-06-27
ELSE PRESS RELEASES FROM THIS DATE:
Potential Alzheimer's drug prevents abnormal blood clots in the brain
2014-06-27
Without a steady supply of blood, neurons can't work. That's why one of the culprits behind Alzheimer's disease is believed to be the persistent blood clots that often form in the brains of Alzheimer's patients, contributing to the condition's hallmark memory loss, confusion and cognitive decline.
New experiments in Sidney Strickland's Laboratory of Neurobiology and Genetics at Rockefeller University have identified a compound that might halt the progression of Alzheimer's by interfering with the role amyloid-β, a small protein that forms plaques in Alzheimer's brains, ...
'Bad' video game behavior increases players' moral sensitivity
2014-06-27
BUFFALO, N.Y. — New evidence suggests heinous behavior played out in a virtual environment can lead to players' increased sensitivity toward the moral codes they violated.
That is the surprising finding of a study led by Matthew Grizzard, PhD, assistant professor in the University at Buffalo Department of Communication, and co-authored by researchers at Michigan State University and the University of Texas, Austin.
"Rather than leading players to become less moral," Grizzard says, "this research suggests that violent video-game play may actually lead to increased moral ...
Ancient ocean currents may have changed pace and intensity of ice ages
2014-06-27
Climate scientists have long tried to explain why ice-age cycles became longer and more intense some 900,000 years ago, switching from 41,000-year cycles to 100,000-year cycles.
In a paper published this week in the journal Science, researchers report that the deep ocean currents that move heat around the globe stalled or may have stopped at that time, possibly due to expanding ice cover in the Northern Hemisphere.
"The research is a breakthrough in understanding a major change in the rhythm of Earth's climate, and shows that the ocean played a central role," says ...
Research gives unprecedented 3-D view of important brain receptor
2014-06-27
PORTLAND, Ore. — Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain — a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression.
The unprecedented view provided by the OHSU research, published online June 22 in the journal Nature, gives scientists new insight into how the receptor — called the NMDA receptor ...
Study: To address climate change, nothing substitutes for reducing CO2 emissions
2014-06-27
The politically expedient way to mitigate climate change is essentially no way at all, according to a comprehensive new study by University of Chicago climatologist Raymond Pierrehumbert.
Among the climate pollutants humans put into the atmosphere in significant quantities, the effects of carbon dioxide (CO2) are the longest-lived, with effects on climate that extend thousands of years after emissions cease. But finding the political consensus to act on reducing CO2 emissions has been nearly impossible. So there has been a movement to make up for that inaction by reducing ...
Some aggressive cancers may respond to anti-inflammatory drugs
2014-06-27
New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis.
Studying triple-negative breast cancer, researchers at Washington University School of Medicine in St. Louis found that some aggressive tumors rely on an antiviral pathway that appears to drive inflammation, widely recognized for roles in cancer, rheumatoid arthritis and other inflammatory diseases.
The tumors that activate this particular antiviral pathway always have dysfunctional forms of the proteins ...
Diamond plates create nanostructures through pressure, not chemistry
2014-06-27
ALBUQUERQUE, N.M. — You wouldn't think that mechanical force — the simple kind used to eject unruly patrons from bars, shoe a horse or emboss the raised numerals on credit cards — could process nanoparticles more subtly than the most advanced chemistry.
Yet, in a current paper in Nature Communications, Sandia National Laboratories researcher Hongyou Fan and colleagues appear to have achieved a start toward that end.
Their newly patented and original method uses simple pressure — a kind of high-tech embossing — to produce finer and cleaner results in forming silver ...
Research may yield new ways to treat antibiotic-resistant TB
2014-06-27
CORVALLIS, Ore. – Scientists in the United States and India have successfully modified the precursor to one of the drugs used to treat tuberculosis, an important first step toward new drugs that can transcend antibiotic resistance issues that experts consider a serious threat to global health.
The findings, reported in the Journal of Biological Chemistry, indicate that a new compound, 24-desmethylrifampicin, has much better antibacterial activity than rifampicin against multi-drug-resistant strains of the bacteria that cause tuberculosis.
Rifampicin and related drugs ...
Youth regularly receive pro-marijuana tweets
2014-06-27
AUDIO:
Twitter has become one of the most popular social media sites among young people, and researchers at Washington University School of Medicine in St. Louis have been looking at Twitter....
Click here for more information.
Hundreds of thousands of American youth are following marijuana-related Twitter accounts and getting pro-pot messages several times each day, researchers at Washington University School of Medicine in St. Louis have found.
The tweets are cause for ...
A new species of moth from the Appalachian Mountains named to honor the Cherokee Nation
2014-06-27
A small, drab and highly inconspicuous moth has been flitting nameless about its special niche among the middle elevations of one of the world's oldest mountain ranges, the southern Appalachian Mountains in North America. A team of American scientists has now identified this new to science species as Cherokeea attakullakulla and described it in a special issue of the open access journal ZooKeys.
In all probability, it has been frequenting these haunts for tens of millions of years before the first humans set foot on this continent, all the while not caring in the least ...